Management of Small Cell Lung Cancer
- 1 September 2007
- Vol. 132 (3) , 324S-339S
- https://doi.org/10.1378/chest.07-1385
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Grading Strength of Recommendations and Quality of Evidence in Clinical GuidelinesChest, 2006
- Positron Emission Tomography in Limited-Stage Small-Cell Lung Cancer: A Prospective StudyJournal of Clinical Oncology, 2004
- Impact of [18F]FDG-PET on the primary staging of small-cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Impact of Positron Emission Tomography on the Management of Patients With Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 2004
- FDG-PET imaging for the staging and follow-up of small cell lung cancer.European Journal of Nuclear Medicine and Molecular Imaging, 2001
- Positron Emission Tomography in the Staging of Small-Cell Lung CancerChest, 2001
- Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agentBritish Journal of Cancer, 2000
- Asymptomatic Brain Metastases (BM) in Small Cell Lung Cancer (SCLC): MR-imaging is Useful at Initial DiagnosisJournal of Neuro-Oncology, 2000
- Bone marrow involvement in anaplastic small cell lung cancer: Diagnosis, hematologic features, and prognostic implicationsCancer, 1986
- Is Bone Marrow Examination in Small-Cell Lung Cancer Really Necessary?Annals of Internal Medicine, 1986